MTFP1 and cancer: Drug development targeting MTFP1, especially by inhibiting MTFP1-induced mitochondrial fragmentation, can impair the metabolic adaptability of cancer cells and increase their sensitivity to conventional chemotherapy and radiotherapy (Yu et al., 2021).